| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 4.22±0.90 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 8.69 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 8.28±2.44 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 133305-88-1 | CAS-1142337-10-7; | CAS-133305-88-1 |
| CHEMBL264188 | DSSTox_CID_28903 | DSSTox_GSID_48683 |
| DSSTox_GSID_48977 | DSSTox_RID_82879 | DSSTox_RID_83171 |
| DTXSID0048977 | Eprinomectin (B1a, B1b mixture) | Eprinomectin B1a |
| NCGC00183133-01 | Tox21_113068 | Tox21_113434 |
| CAS Number | 133305-88-1 |
| PubChem Compound | 44460585 |